Clinical Trial Update: Naloxone for the Treatment of Opioid-Induced Pruritus [Phase 2, Phase 3]

View source ↗

Summary

The document reports completion of Phase 2 and Phase 3 trials assessing the use of naloxone to treat opioid-induced pruritus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-induced Pruritus

Drugs mentioned

• Naloxone (Naloxone)

Snippet

Sponsor: University of British Columbia | Conditions: Pruritus | Phase 2, Phase 3 | Status: COMPLETED